Super manipulated by GS, who do work for NVO and LLY and want to protect them. Fuck them. The data are better, 25% SI, and p3-ready in MASH and obesity - right when FDA is making it easier. I hope they get burned hard. There are bidding wars for MASH/obesity drugs right now...they should know better.

---

$ALT is being manipulated by GS to protect NVO and LLY...but data are better. 25% SI. This could run hard when buyout rumors start, bidding wars in MASH/obesity drugs and a paucity of p3-ready options.

---

100% being shorted by GS to protect NVO and LLY. Data are better and heavily shorted.

---

$ALT looks primed for a breakout soon.  Late Breaking data & oral presentation @ AASLD nov 8-11.  Obesity phase 3 ready. MASH resolution & fibrosis improvement best in class at 24 weeks once FDA accepts NITs any day.   Renewed bidding wars between pfizer and Novo for a phase 1 obesity asset the same day Lilly announces their glp1 is the best selling drug in the world.   GS has been suppressing this SP indiscriminately to protect the market for their customers NOVO & LILly.  A huge risk reward value only days away from business updates  AND key oral presentation at THE liver conference of the year.  Now is the time to load up!  This drug pemvutide is next generation.  Better quality weight loss than good diet and we exercise(21% lean muscle loss vs 24% good diet & Exercise), great tolerability due to proprietary euport technology, 74 % liver fat reduction.  6% weight loss at 24 weeks. Its a healthy new liver for all drinkers with a side of weight loss.  

---

Currently holding $1M+, 60,000 shares of RKT... [https://www.reddit.com/r/wallstreetbets/comments/1oj76qk/rkt\_60k\_shares1m\_earnings\_tomorrow\_rkt\_price/](https://www.reddit.com/r/wallstreetbets/comments/1oj76qk/rkt_60k_shares1m_earnings_tomorrow_rkt_price/) BTIG and BoA have $25 targets for it, for '26. GS has $22, by '26.

---

Because Larry Ellison scammed this exact way back during the original tech bubble? They posted an EPS loss and lied and said they have orders for 2030 that surely won't be canceled. Might want to get out now before this goes sub 200. JPM/GS shilling it every time it dips will only work for so long.

---

Fake bers in chat trying to jinx for the real gs 😮‍💨

---

Real Gs move in silence like lasagna

---

And as I've said, ANY current PE that the "algos" compute is GARBAGE. Most analysts have NOT updated their forecasts, to account for COOP EPS boost. They will do so, AFTER earnings/projections are officially announced. The one's that have pre-forecasted with COOP earnings, have the stock in the 20's (GS-$22, BoA - $25, BTIG - $25). And that's not counting $600M in savings/synergies expected from the RDFN and COOP acquisitions over the next year.

---

As I said before, good luck. I'm seeing the forward PE looking up the ticker on Schwab. Along with the other analyst reports I mentioned in my post outside of GS.

---